Coherus Oncology, Inc.

US$0.77As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CHRSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (29.97%)
Div yield —
ROE (178.39%)
Biotechnology
Beta (5Y) 1.05
PE TTM —
TSR TTM (54.17%)
Mkt cap US$119.0M
ROIC (1586.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.743
(3.48%)
1.74%
Sell 2|1|8|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(10.54%)
(10.69%)
(8.76%)
2.78%
Revenue$M
8.295
8.064
8.452
8.374
3.82%
2.22%
5.96%
(0.41%)
Peers (US$119.0M)
Cap (US$)
PE
118.3M
—
118.3M
—
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
0.932
(0.160)
(0.158)
EBIT/Intx
0.745
0.111
0.100
Own earn%
15.89
48.49
51.27
Sh yield%
21.37
21.54
19.33
Owners
Insiders/Inst%
4.28
66.91
Short interest%
0.86
SBC / revenue%
3.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
26